Rebecca A Marsh

Years Active: 2018-2021
Publications (10 Years): 4

This page only lists publications with an associated author ORCID identifier.

Publications

Danielle E Arnold, Rofida Nofal, Connor Wakefield, Kai Lehmberg, Katharina Wustrau, Michael H Albert, Emma C Morris, Jennifer R Heimall, Nancy J Bunin, Ashish Kumar, Michael B Jordan, Theresa Cole, Sharon Choo, Tim Brettig, Carsten Speckmann, Stephan Ehl, Malgorzata Salamonowicz, Justin Wahlstrom, Kanchan Rao, Claire Booth, Austen Worth, Rebecca A Marsh
Reduced-Intensity/Reduced-Toxicity Conditioning Approaches Are Tolerated in XIAP Deficiency but Patients Fare Poorly with Acute GVHD. Journal of clinical immunology (2021)
Pooja Khandelwal, Ashley Teusink-Cross, Ashish R Kumar, Jacob J Bleesing, Parinda A Mehta, Michael B Jordan, Sharat Chandra, Stella M Davies, Rebecca A Marsh
Daratumumab for the management of autoimmune cytopenias in children and young adults: a case series. British journal of haematology 194 (5) (2021)
Danielle E Arnold, Chie Emoto, Tsuyoshi Fukuda, Min Dong, Alexander A Vinks, Adam Lane, Kelly McIntosh, Lisa Neumeier, Arjan C Lankester, Federica Achini, Ashley Teusink-Cross, Sharat Chandra, Michael B Jordan, Adam S Nelson, Kasiani C Myers, Stella M Davies, Parinda A Mehta, Rebecca A Marsh
A prospective pilot study of a novel alemtuzumab target concentration intervention strategy. Bone marrow transplantation 56 (12) (2021)
Rebecca A Marsh, Elie Haddad
How i treat primary haemophagocytic lymphohistiocytosis. British journal of haematology 182 (2) (2018)

Rebecca A Marsh.css-eqlu8i{font-size:small;padding-left:4px;}